Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | LEXX Lexaria Bioscience Corp. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $3.10 -3.6% | $15.40 -3.7% |
| StockIQ Score | 33F Weak Risk: High | 35F Weak Risk: High |
| Technical | 7F | 13F |
| Fundamental | 35F | 35F |
| Growth | 40D | 50C- |
| Fair Value | 38F | 38F |
| News | 68B- | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Lexaria (LEXX) outperforms Ascentage (AAPG) in technicals (85 vs. 18) and investor sentiment (54 vs. 37), reflecting stronger market trends and confidence. However, AAPG shows better growth potential (50 vs. 40) and equal valuation (38 vs. 38). Both share the same fundamental score of 35, but LEXX’s moderate rating contrasts with AAPG’s weak classification.
